两家公司表示,在合作的初始阶段,Ares开发了一个数字抗感染平台,将微生物学实验室实践与先进的生物信息学和人工智能方法相结合,以帮助识别有效的抗菌化合物...查看全文
蹊之美股生物医药2021-10-08 00:15
作者:林出
微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
Voyager Therapeutics (NASDAQ:VYGR) +56%
Acer Therapeutics (NASDAQ:ACER) +16%
Molecular Partners (NASDAQ:MOLN) +10%
Rafael (NYSE:RFL) +6%
Arcturus Therapeutics (NASDA...查看全文
东哥_Singapore2021-03-08 23:42
$Jaguar Health(JAGX)$ 给力点啊,速度冲2.5!刚才在2.9的OPGN跟1.85的你之间,最后选的你!不要让我失望啊!OPGN已经爆拉了!!!$OpGen(OPGN)$查看全文
$OpGen(OPGN)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001079973-23-000549 Act: 34 Size: 39 KB 网页链接
$OpGen(OPGN)$ DEF 14A Other definitive proxy statements Accession Number: 0001079973-23-000546 Act: 34 Size: 454 KB 网页链接
$OpGen(OPGN)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001079973-23-000502 Act: 34 Size: 215 KB 网页链接
$OpGen(OPGN)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001079973-23-000500 Act: 34 Size: 217 KB 网页链接
$OpGen(OPGN)$ S-1 General form for registration of securities under the Securities Act of 1933 Accession Number: 0001079973-23-000458 Act: 33 Size: 1 MB 网页链接
$OpGen(OPGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001079973-23-000408 Size: 7 KB 网页链接
$OpGen(OPGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001079973-23-000409 Size: 7 KB 网页链接
$OpGen(OPGN)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001079973-23-000394 Act: 34 Size: 440 KB 网页链接
$OpGen(OPGN)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001079973-23-000391 Act: 34 Size: 8 MB 网页链接
$OpGen(OPGN)$ 8-K Current report, item 4.01 Accession Number: 0001079973-23-000336 Act: 34 Size: 196 KB 网页链接